Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 2
1991 3
1992 5
1994 1
1995 2
1996 3
1997 5
1998 2
1999 3
2000 2
2001 3
2002 3
2003 2
2004 3
2005 4
2006 3
2007 7
2008 5
2009 4
2010 7
2011 5
2012 6
2013 6
2014 2
2015 2
2016 3
2017 2
2018 4
2019 3
2020 4
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.
Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher-Berry C, Barrientos-Pérez M, Bismuth E, Dib S, Cho JI, Cox D; AWARD-PEDS Investigators. Arslanian SA, et al. N Engl J Med. 2022 Aug 4;387(5):433-443. doi: 10.1056/NEJMoa2204601. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35658022 Clinical Trial.
The Third Injection Technique Workshop in Athens (TITAN).
Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, Letondeur C, Sauvanet JP, Tubiana-Rufi N, Strauss K. Frid A, et al. Among authors: tubiana rufi n. Diabetes Metab. 2010 Sep;36 Suppl 2:S19-29. doi: 10.1016/S1262-3636(10)70003-3. Diabetes Metab. 2010. PMID: 20933206
New injection recommendations for patients with diabetes.
Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, Letondeur C, Sauvanet JP, Tubiana-Rufi N, Strauss K; Scientific Advisory Board for the Third Injection Technique Workshop. Frid A, et al. Among authors: tubiana rufi n. Diabetes Metab. 2010 Sep;36 Suppl 2:S3-18. doi: 10.1016/S1262-3636(10)70002-1. Diabetes Metab. 2010. PMID: 20933208 Review.
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump Therapy.
Coutant R, Bismuth E, Bonnemaison E, Dalla-Vale F, Morinais P, Perrard M, Trely J, Faure N, Bouhours-Nouet N, Levaillant L, Farret A, Storey C, Donzeau A, Poidvin A, Amsellem-Jager J, Place J, Quemener E, Hamel JF, Breton MD, Tubiana-Rufi N, Renard E. Coutant R, et al. Among authors: tubiana rufi n. Diabetes Technol Ther. 2023 Jun;25(6):395-403. doi: 10.1089/dia.2022.0518. Epub 2023 Apr 6. Diabetes Technol Ther. 2023. PMID: 36927054 Clinical Trial.
Outcomes of hybrid closed-loop insulin delivery activated 24/7 versus evening and night in free-living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial.
Renard E, Tubiana-Rufi N, Bonnemaison E, Coutant R, Dalla-Vale F, Bismuth E, Faure N, Bouhours-Nouet N, Farret A, Storey C, Donzeau A, Poidvin A, Amsellem-Jager J, Place J, Breton MD; Free-life Kid AP Study Group. Renard E, et al. Among authors: tubiana rufi n. Diabetes Obes Metab. 2022 Mar;24(3):511-521. doi: 10.1111/dom.14605. Epub 2021 Dec 1. Diabetes Obes Metab. 2022. PMID: 34816597 Clinical Trial.
Practical implementation of automated closed-loop insulin delivery: A French position statement.
Tubiana-Rufi N, Schaepelynck P, Franc S, Chaillous L, Joubert M, Renard E, Reznik Y, Abettan C, Bismuth E, Beltrand J, Bonnemaison E, Borot S, Charpentier G, Delemer B, Desserprix A, Durain D, Farret A, Filhol N, Guerci B, Guilhem I, Guillot C, Jeandidier N, Lablanche S, Leroy R, Melki V, Munch M, Penfornis A, Picard S, Place J, Riveline JP, Serusclat P, Sola-Gazagnes A, Thivolet C, Hanaire H, Benhamou PY; SFD SFD Paramedical SFE SFEDP AJD FFD FENAREDIAM and CNP-EDN. Tubiana-Rufi N, et al. Diabetes Metab. 2021 May;47(3):101206. doi: 10.1016/j.diabet.2020.10.004. Epub 2020 Nov 2. Diabetes Metab. 2021. PMID: 33152550
Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis.
Guerci B, Tubiana-Rufi N, Bauduceau B, Bresson R, Cuperlier A, Delcroix C, Durain D, Fermon C, Le Floch JP, Le Devehat C, Melki V, Monnier L, Mosnier-Pudar H, Taboulet P, Hanaire-Broutin H. Guerci B, et al. Among authors: tubiana rufi n. Diabetes Metab. 2005 Sep;31(4 Pt 1):401-6. doi: 10.1016/s1262-3636(07)70211-2. Diabetes Metab. 2005. PMID: 16369204 Review.
98 results